Intended Use

The device is intended to capture, analyze and report symptomatic and asymptomatic cardiac events and continuous electrocardiogram information for long-term monitoring in patients 18 years or older.

Technology

The system is software-based, utilizing AI algorithms including an AutoTrigger Engine and ECGDL software to analyze ECG data from wearable monitors, automatically detecting arrhythmias and cardiac rhythms, with results reviewed by technicians before report generation.

Performance

The device underwent design verification and validation testing demonstrating conformance with FDA-recognized standards for risk management, software lifecycle, and ambulatory ECG safety and performance, confirming substantial equivalence to predicate devices without new safety or efficacy concerns.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/8/2022

    6 months
  • 2

    FDA Approval

    2/15/2023

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.